2023 Updated Late Effects Guidelines Webinar

The number of long-term survivors of hematopoietic cell transplantation (HCT) and cellular therapy is rapidly expanding. Guidelines for the screening and preventative practices for HCT survivors was last published in 2012. This webinar will review the 2023 updated guidelines for pediatric and adult survivorship for HCT and cellular therapy. We will highlight changes to the guidelines from 2012, reflecting contemporary practice and data, emphasizing special needs of patients with distinct HCT indications and co-morbidities, as well as complications such as graft-versus-host disease. Finally, we will address the gaps and challenges in survivorship care for transplant/cellular therapy patients.